Biolase (BIOL) Reports Q3 Loss of $0.09/Share
Get Alerts BIOL Hot Sheet
Join SI Premium – FREE
Biolase (NASDAQ: BIOL) reported Q3 EPS of ($0.09), versus ($0.08) reported last year. Revenue for the quarter came in at $11.2 million, versus $1.5 million reported last year.
For earnings history and earnings-related data on Biolase (BIOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Spotify (SPOT) jumps 10% as Q1 revenue, gross margins beat Street's estimates
- Sherwin-Williams (SHW) Misses Q1 EPS by 5c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!